Eli Lilly is currently studying retatrutide in several phase-3 clinical trials for obesity, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatosis liver disease
While BPC-157 Peptide Nasal Spray has gained significant attention in research, scientists also study B7-33 and TB500 for their distinct effects
Are compounded semaglutide and tirzepatide from PlexusDx truly HSA eligible
This precision-medicine approach reduces trial-and-error adjustments and helps you sleep better while maximizing the benefits of your weight-loss therapy
In CKD, oxidative stress and inflammation play major roles in renal damage
Given its dual roles in proliferation control and immune regulation, the prognostic implications of sermorelin were assessed